D
Diabeloop
Medical device company for diabetes and closed-loop system and also develops disruptive technological innovations to automate the treatment of diabetes
About Diabeloop
Diabeloop is a health-tech startup that operates in the medical device industry, specifically focusing on diabetes management. The company has developed a self-learning algorithm that uses therapeutic artificial intelligence (AI) to automate the treatment of Type 1 diabetes. This means that the system learns from the patient's behavior and adjusts the treatment accordingly, reducing the need for constant decision-making by the patient.
Read full description
The company's primary market is individuals living with Type 1 or Type 2 diabetes, and their families. Diabeloop's business model is centered around the development and sale of its AI-powered medical device. The device is currently marketed in France and several other European countries, and the company has signed development agreements with international partners such as Roche Diabetes Care, ViCentra, SOOIL, Terumo Corporation, and BIOCORP.
Diabeloop's revenue is generated through the sale of its medical device to patients and healthcare providers. The company has recently completed its third round of financing, raising a total of 70 million euros to support its international expansion and research and development activities.
In simple terms, Diabeloop is a company that uses AI to help people with diabetes manage their condition more easily and effectively. It sells its product in Europe and is looking to expand internationally.
At a glance
- Status
- Operational
- Founded
- 2015
- Headquarters
- Grenoble, France
- Employees
- 81
- Open positions
- 2
- Dealroom signal
- 68.0/100
- Industry
- Health
- Sub-industry
- BioTechnology, Medical Devices
- Sector
- Biotech & Life Sciences, Personal Health, Diabetes, Biotechnology, Remote Monitoring, Core AI, Spinout
- Technology
- Artificial Intelligence, Hardware, Deep Tech
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VCOther financing | Mar 2024 | $17M | $385M | Undisclosed | ↗ |
| GRANTOther financing | Jan 2024 | $55K | — | EIT Health | — |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Diabeloop is 1.4K monthly website visits, down 22.2% over the last three months. Diabeloop's team declined 4.7% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed2 investors entered at this stage
EIT Health
European Innovation Council
Series A9 investors entered at this stage
Crédit Agricole
Kreaxi
Sofimac Régions
ALIAD (Air Liquide)
Odyssée Venture
Supernova Invest
Cemag Invest
Sofimac Innovation
Crédit Agricole Sud Rhône Alpes
Series B and later7 investors entered at this stage
Bpifrance
LBO France
Terumo
UI Investissement
PROMONTOIRES
CERITD
AGIR A DOM
Other known investors4 additional known investors
CEA-Leti
CNRS Innovation
French Alternative Energies and Atomic Energy Commission - CEA
French National Centre for Scientific Research - CNRS
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Diabeloop on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Diabeloop’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.